Literature DB >> 20804144

Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase.

Phillip A Schwartz1, Mathew J Vetticatt, Vern L Schramm.   

Abstract

Human thymidine phosphorylase (hTP) is responsible for thymidine (dT) homeostasis, and its action promotes angiogenesis. In the absence of phosphate, hTP catalyzes a slow hydrolytic depyrimidination of dT yielding thymine and 2-deoxyribose (dRib). Its transition state was characterized using multiple kinetic isotope effect (KIE) measurements. Isotopically enriched thymidines were synthesized enzymatically from glucose or (deoxy)ribose, and intrinsic KIEs were used to interpret the transition state structure. KIEs from [1'-(14)C]-, [1-(15)N]-, [1'-(3)H]-, [2'R-(3)H]-, [2'S-(3)H]-, [4'-(3)H]-, and [5'-(3)H]dTs provided values of 1.033 ± 0.002, 1.004 ± 0.002, 1.325 ± 0.003, 1.101 ± 0.004, 1.087 ± 0.005, 1.040 ± 0.003, and 1.033 ± 0.003, respectively. Transition state analysis revealed a stepwise mechanism with a 2-deoxyribocation formed early and a higher energetic barrier for nucleophilic attack of a water molecule on the high energy intermediate. An equilibrium exists between the deoxyribocation and reactants prior to the irreversible nucleophilic attack by water. The results establish activation of the thymine leaving group without requirement for phosphate. A transition state constrained to match the intrinsic KIEs was found using density functional theory. An active site histidine (His116) is implicated as the catalytic base for activation of the water nucleophile at the rate-limiting transition state. The distance between the water nucleophile and the anomeric carbon (r(C-O)) is predicted to be 2.3 A at the transition state. The transition state model predicts that deoxyribose adopts a mild 3'-endo conformation during nucleophilic capture. These results differ from the concerted bimolecular mechanism reported for the arsenolytic reaction (Birck, M. R.; Schramm, V. L. J. Am. Chem. Soc. 2004, 126, 2447-2453).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804144      PMCID: PMC2948953          DOI: 10.1021/ja105041j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  42 in total

Review 1.  The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.

Authors:  C Cole; A J Foster; S Freeman; M Jaffar; P E Murray; I J Strafford
Journal:  Anticancer Drug Des       Date:  1999-10

2.  Glycosidase mechanisms: anatomy of a finely tuned catalyst.

Authors:  D L Zechel; S G Withers
Journal:  Acc Chem Res       Date:  2000-01       Impact factor: 22.384

3.  Conformational equilibrium isotope effects in glucose by (13)C NMR spectroscopy and computational studies.

Authors:  B E Lewis; V L Schramm
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

4.  Structural analysis of adenine phosphoribosyltransferase from Saccharomyces cerevisiae.

Authors:  W Shi; K S Tanaka; T R Crother; M W Taylor; S C Almo; V L Schramm
Journal:  Biochemistry       Date:  2001-09-11       Impact factor: 3.162

5.  Kinetic isotope effect studies of the reaction catalyzed by uracil DNA glycosylase: evidence for an oxocarbenium ion-uracil anion intermediate.

Authors:  R M Werner; J T Stivers
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

6.  Ribocation transition state capture and rebound in human purine nucleoside phosphorylase.

Authors:  Mahmoud Ghanem; Andrew S Murkin; Vern L Schramm
Journal:  Chem Biol       Date:  2009-09-25

7.  Binding equilibrium isotope effects for glucose at the catalytic domain of human brain hexokinase.

Authors:  Brett E Lewis; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2003-04-23       Impact factor: 15.419

8.  Role of histidine-85 in the catalytic mechanism of thymidine phosphorylase as assessed by targeted molecular dynamics simulations and quantum mechanical calculations.

Authors:  Jesús Mendieta; Sonsoles Martín-Santamaría; Eva-María Priego; Jan Balzarini; María-José Camarasa; María-Jesús Pérez-Pérez; Federico Gago
Journal:  Biochemistry       Date:  2004-01-20       Impact factor: 3.162

Review 9.  Enzymatic transition state poise and transition state analogues.

Authors:  Vern L Schramm
Journal:  Acc Chem Res       Date:  2003-08       Impact factor: 22.384

Review 10.  Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.

Authors:  F Focher; S Spadari
Journal:  Curr Cancer Drug Targets       Date:  2001-08       Impact factor: 3.428

View more
  13 in total

1.  Uridine phosphorylase from Trypanosoma cruzi: kinetic and chemical mechanisms.

Authors:  Rafael G Silva; Vern L Schramm
Journal:  Biochemistry       Date:  2011-09-27       Impact factor: 3.162

2.  Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase.

Authors:  Phillip A Schwartz; Mathew J Vetticatt; Vern L Schramm
Journal:  Biochemistry       Date:  2011-02-03       Impact factor: 3.162

Review 3.  Mechanisms for enzymatic cleavage of the N-glycosidic bond in DNA.

Authors:  Alexander C Drohat; Atanu Maiti
Journal:  Org Biomol Chem       Date:  2014-11-14       Impact factor: 3.876

4.  Structural investigation of the thymidine phosphorylase from Salmonella typhimurium in the unliganded state and its complexes with thymidine and uridine.

Authors:  Vladislav V Balaev; Alexander A Lashkov; Azat G Gabdulkhakov; Maria V Dontsova; Tatiana A Seregina; Alexander S Mironov; Christian Betzel; Al'bert M Mikhailov
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-02-19       Impact factor: 1.056

5.  Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.

Authors:  Qiang Zhang; Yang Zhang; Xuejiao Hu; Yuan Qin; Weilong Zhong; Jing Meng; Ting Xiao; Chunhong Zhang; Meng Li; Shuang Chen; Huijuan Liu; Yanrong Liu; Tao Sun; Cheng Yang
Journal:  Lab Invest       Date:  2017-05-22       Impact factor: 5.662

6.  Transition-state analysis of Trypanosoma cruzi uridine phosphorylase-catalyzed arsenolysis of uridine.

Authors:  Rafael G Silva; Mathew J Vetticatt; Emilio F Merino; Maria B Cassera; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2011-06-03       Impact factor: 15.419

7.  Rational Design of an Orally Active Anticancer Fluoropyrimidine, Pencitabine, a Hybrid of Capecitabine and Gemcitabine.

Authors:  Thomas I Kalman
Journal:  ACS Med Chem Lett       Date:  2022-02-21       Impact factor: 4.345

Review 8.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

Review 9.  Role of Base Excision "Repair" Enzymes in Erasing Epigenetic Marks from DNA.

Authors:  Alexander C Drohat; Christopher T Coey
Journal:  Chem Rev       Date:  2016-08-08       Impact factor: 60.622

10.  Experimental and computational analysis of the transition state for ribonuclease A-catalyzed RNA 2'-O-transphosphorylation.

Authors:  Hong Gu; Shuming Zhang; Kin-Yiu Wong; Brian K Radak; Thakshila Dissanayake; Daniel L Kellerman; Qing Dai; Masaru Miyagi; Vernon E Anderson; Darrin M York; Joseph A Piccirilli; Michael E Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.